BeiGene Valuation

688235 Stock   189.78  1.98  1.05%   
At this time, the firm appears to be overvalued. BeiGene shows a prevailing Real Value of USD179.52 per share. The current price of the firm is USD189.78. Our model approximates the value of BeiGene from analyzing the firm fundamentals such as Current Valuation of 162.38 B, return on equity of -0.23, and Profit Margin of (0.26) % as well as examining its technical indicators and probability of bankruptcy.
Price Book
10.3356
Enterprise Value
162.4 B
Enterprise Value Ebitda
(86.19)
Price Sales
7.4863
Forward PE
526.3158
Overvalued
Today
189.78
Please note that BeiGene's price fluctuation is very steady at this time. Calculation of the real value of BeiGene is based on 3 months time horizon. Increasing BeiGene's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BeiGene is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BeiGene Stock. However, BeiGene's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  189.78 Real  179.52 Hype  187.48
The real value of BeiGene Stock, also known as its intrinsic value, is the underlying worth of BeiGene Company, which is reflected in its stock price. It is based on BeiGene's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BeiGene's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
176.99
Downside
179.52
Real Value
206.58
Upside
Estimating the potential upside or downside of BeiGene helps investors to forecast how BeiGene stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BeiGene more accurately as focusing exclusively on BeiGene's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.52-0.52-0.52
Details
Hype
Prediction
LowEstimatedHigh
184.95187.48190.01
Details

BeiGene Cash

2.95 Billion

BeiGene Total Value Analysis

BeiGene is presently forecasted to have takeover price of 162.38 B with market capitalization of 175.99 B, debt of 688.37 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BeiGene fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
162.38 B
175.99 B
688.37 M

BeiGene Investor Information

About 32.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 4.62. BeiGene had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from BeiGene's historical financial statements, BeiGene is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February.

BeiGene Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BeiGene has an asset utilization ratio of 42.35 percent. This suggests that the Company is making USD0.42 for each dollar of assets. An increasing asset utilization means that BeiGene is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

BeiGene Ownership Allocation

BeiGene holds a total of 115.06 Million outstanding shares. 30% of BeiGene outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

BeiGene Profitability Analysis

The company reported the revenue of 2.46 B. Net Loss for the year was (881.71 M) with profit before overhead, payroll, taxes, and interest of 19.67 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BeiGene's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BeiGene and how it compares across the competition.

About BeiGene Valuation

The stock valuation mechanism determines BeiGene's current worth on a weekly basis. Our valuation model uses a comparative analysis of BeiGene. We calculate exposure to BeiGene's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BeiGene's related companies.
Last ReportedProjected for Next Year
Gross Profit2.4 B2.5 B

Complementary Tools for BeiGene Stock analysis

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope